Cui Z, Hayashi K, Bach P, Milloy MJ, Kerr T Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: a prospective cohort study in Vancouver, Canada J Subst Use Addict Treat, 2023. PubMed

Bach P, Ti L, Hayashi K, Cui Z, Milloy MJ, Fairbairn N Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018 J Subst Use Addict Treat, 2023. PubMed

Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME Use of cannabis as a harm reduction strategy among people who use drugs: a cohort study Cannabis Cannabinoid Res, 2023. PubMed

van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study Harm Reduct J, 2023. PubMed

Goodyear T, Oliffe JL, Parent N, Mniszak C, Jenkins E, Knight R Differentiating the role of alcohol in young men's use of substances with sex: a qualitative study Harm Reduct J, 2023. PubMed

Reddon H, Fairbairn N, Grant C, Milloy MJ Experiencing homelessness and progression through the HIV cascade of care among people who use drugs AIDS, 2023. PubMed

Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL Development of a neural network model to predict the presence of fentanyl in community drug samples PLoS One, 2023. PubMed

Morgan J, Neufeld SD, Holroyd H, Ruiz J, Taylor T, Nolan S, Glegg S Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience using illicit drugs and harm reduction workers Harm Reduct J, 2023. PubMed

Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Choi JC, Mok WY, Socías ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: secondary analysis of a pragmatic randomized trial Drug Alcohol Depend, 2023. PubMed

Mayer S, Boyd J, Fairbairn N, Chapman J, Brohman I, Jenkins E, McNeil R Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada Int J Drug Policy, 2023. PubMed